期刊文献+

选择性COX-2抑制剂NS-398诱导白血病细胞凋亡的作用机制 被引量:8

Effect of selective cyclooxygenase-2 inhibitor NS-398 on cell apoptosis in K562 cells and its underlying mechanism
下载PDF
导出
摘要 目的探讨选择性环氧合酶-2(COX-2)抑制剂NS-398诱导白血病细胞系K562细胞凋亡的分子机制。方法采用流式细胞术检测细胞凋亡;采用蛋白印迹法(Western blot)检测凋亡相关蛋白Bcl-2、半胱氨酸酶-3(Caspase-3)的表达;并应用流式细胞术检测Caspase-3的活性。结果①NS-398作用K562细胞24h后,对照组未出现凋亡峰,各药物处理组(100~400μmol·L-1)均出现明显的凋亡峰,其凋亡率分别为(10.51±1.04)%、(27.79±2.40)%、(45.72±3.32)%和(60.22±2.03)%(P【0.01)。②不同浓度NS-398处理后,K562细胞中Bcl-2蛋白表达下降,而Caspase-3蛋白表达增加,与对照组相比差异具有显著性(P【0.05)。③NS-398能以剂量依赖方式促进Caspase-3活性的增加,表达活化Caspase-3的细胞百分率分别为(2.67±0.22)%、(9.53±0.15)%、(21.28±0.43)%、(39.63±0.8)%和(63.40±0.69)%(P【0.01)。结论选择性COX-2抑制剂NS-398可能通过调节Bcl-2蛋白表达、活化Caspase-3,从而诱导白血病K562细胞凋亡。 Aim To investigate the effect of selective cyclooxygenase-2 inhibitor, NS-398, on cell apoptosis in leukemia cell line K562 cells and its underlying mechanism. Methods Apoptotic cell percentage was examined by flow cytometry(FCM). The protein expression of Bcl-2 and Caspase-3 was detected by Western blot, and the activity of Caspase-3 was checked by FCM. Results NS-398 induced the cell apoptosis in K562 cells in a dose-dependent manner. After NS-398 treatment, the expression of Bcl-2 protein was downregulated, whereas the expression of Caspase-3 protein was upregulated. Moreover,the activity of Caspase-3 was increased in a dose-dependent way after NS-398 treatment. Conclusion Selective cyclooxygenase-2 inhibitor,NS-398,significantly induced apoptosis in K562 cells. The underlying mechanism might be related to the downregulation of Bcl-2 and the activation of Caspase-3.
出处 《中国药理学通报》 CAS CSCD 北大核心 2007年第7期899-902,共4页 Chinese Pharmacological Bulletin
基金 湖北省教育厅基金资助项目(NoD200511008)
关键词 NS-398 环氧合酶-2 凋亡 K562细胞 NS-398 cyclooxygenase-2 apoptosis K562 cell
  • 相关文献

参考文献12

  • 1刘俊茹,齐凤英,李丽,左连富,郭建文,刘江惠.尼美舒利对人食管癌细胞Eca-109 COX-2表达及生长的抑制作用[J].中国药理学通报,2005,21(9):1084-1088. 被引量:5
  • 2周旭春,唐承薇,刘纯伦,王春晖.罗非昔布联合奥曲肽增强对胰腺癌生长的抑制作用[J].中国药理学通报,2003,19(11):1231-1234. 被引量:4
  • 3Gee J,Lee I L,Jendiroba D,et al.Selective cyclooxygenase-2in-hibitors inhibit growth and induce apoptosis of bladder cancer[].Oncology Reports.2006
  • 4Waskwich C,Blumenthal R D,Li H,et al.Celecoxib exhibits the greatest potency amongst cyclooxygenase(COX)inhibitors fo growth inhibition of COX-2-negative hematopoietic and epithelia cell lines[].Cancer Research.2002
  • 5Cai J,Yang J,Jones D P.Mitochondrial control of apoptosis:the role of cytochrome c[].Biochimica et Biophysica Acta.1998
  • 6Anto R J,Mukhopadhyay A,Denning K,et al.Curcumin(diferu-loylmethane)induces apoptosis through activation of caspase-8,BID cleavage and cytochrome c release:its suppression by ectopic expression of bcl-2and bcl-xl[].Carcinogenesis.2002
  • 7Cao Y,Prescott S M.Many actions of cyclooxygenase-2in cellula dynamics and in cancer[].Journal of Cellular Physiology.2002
  • 8Dannhardt G,Kiefer W.Cyclooxygenase inhibitor2current status and future prospects[].European Journal of Medical Chemistry.2001
  • 9Shirahama T,Arima J,Akiba S,et al.Relation between cycloox-ygenase-2expression and tumor invasiveness and patient surviva in transitional cell carcinoma of the urinary bladder[].Cancer.2001
  • 10Han S,Roman J.COX-2inhibitors suppress lung cancer cel growth by inducing p21via COX-2independent signals[].Lung Cancer.2006

二级参考文献30

  • 1周廷潮 韩锐 胥彬 韩锐主编.多种药物协同及拮抗作用的定量分析原理在化疗的应用[A].韩 锐主编.肿瘤化学预防及药物治疗[C].北京:北京医科大学中国协和医科大学联合出版社,1991.315~20.
  • 2Rosenberg L. Pancreatic cancer: Does octreotide offer any promise? Chemotherapy, 2001 ;47(Suppl 2) : 134-49.
  • 3Rosenberg L. Pancreatic cancer. Drugs, 2000;59(5) -1071-89.
  • 4Molina MA, Sitja-Arnau M, LemoineM G et al. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal antiinflammatory drugs. Cancer Res, 1999;59(9) :4356-62.
  • 5Tang C, Biemond I, Lamers CB. Expression of peptide receptors in human exocrine tumors of the pancreas. Br J Cancer,1997:75(10):1467-73.
  • 6Husain SS, Szabo IL, Pai R etal. MAPK (ERK2) kinase-a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth. Life Sci, 2001;69(25-26):3045-54.
  • 7Masferrer JL, Leahy KM, Koki AT et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res,2000;60(5):1306-11.
  • 8Ding XZ, Tong WG, Adrian TE. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Anticancer Res , 2000 ; 20( 4 ) :2625-31.
  • 9Lanxa FL, Rack MF, Callison DA et al. A pilot endoscopic study of the gastroduodenal effects of SC-58635, a novel COX-2-selective inhibitor. Gastroenterology, 1997 ; 112(6) : A194.
  • 10Rhind SG, Gannon GA, Suzui M et al. Indomethacin inhibits circulating PGE2 and reverses postexercise suppression of natural killer cell activity. Am J Physiol, 1999;276(5 Pt 2) :1496-505.

共引文献7

同被引文献78

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部